Enovis to Participate in the Goldman Sachs Global Healthcare Conference
Enovis Corporation (NYSE: ENOV) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on June 13, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Enovis Corporation (NYSE: ENOV) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on June 13, 2022. CEO Matt Trerotola and CFO Chris Hix will engage with investors at the event in Rancho Palos Verdes, California. The company, previously known as Colfax Corporation, focuses on innovative medical technology aimed at improving patient outcomes and transforming healthcare workflows.
For more details, visit www.enovis.com.
Details
News Market Reaction – ENOV
The recorded move for ENOV in the trading session of this news was +0.60%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Wilmington, DE, June 06, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on Monday, June 13, 2022. Matt Trerotola, CEO, and Chris Hix, CFO, will be meeting with investors at the conference which is scheduled to take place in Rancho Palos Verdes, California.
ABOUT ENOVIS™
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com.
Derek Leckow
Vice President, Investor Relations
Enovis Corporation
+1-302-252-9129
investorrelations@enovis.com
Source: Enovis Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.